Zepp Health (NYSE:ZEPP) Shares Down 5.2% – Here’s Why

Shares of Zepp Health Co. (NYSE:ZEPPGet Free Report) were down 5.2% during trading on Tuesday . The stock traded as low as $2.80 and last traded at $2.89. Approximately 9,017 shares changed hands during mid-day trading, a decline of 52% from the average daily volume of 18,976 shares. The stock had previously closed at $3.05.

Wall Street Analyst Weigh In

Separately, Fundamental Research set a $14.65 price target on Zepp Health and gave the stock a “buy” rating in a research note on Tuesday, November 26th.

Check Out Our Latest Analysis on Zepp Health

Zepp Health Stock Performance

The stock’s 50 day simple moving average is $3.11 and its two-hundred day simple moving average is $2.95. The company has a market cap of $42.00 million, a PE ratio of -1.12 and a beta of 0.64. The company has a quick ratio of 0.87, a current ratio of 1.21 and a debt-to-equity ratio of 0.13.

Hedge Funds Weigh In On Zepp Health

A hedge fund recently bought a new stake in Zepp Health stock. Virtu Financial LLC bought a new stake in Zepp Health Co. (NYSE:ZEPPFree Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 13,056 shares of the company’s stock, valued at approximately $57,000. Virtu Financial LLC owned 0.09% of Zepp Health at the end of the most recent quarter. 52.61% of the stock is currently owned by institutional investors and hedge funds.

About Zepp Health

(Get Free Report)

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura.

Recommended Stories

Receive News & Ratings for Zepp Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zepp Health and related companies with MarketBeat.com's FREE daily email newsletter.